Vimang is a standardized extract derived from Mango bark (Mangifera Indica L.), commonly
used as anti-inflammatory phytomedicine, which has recently been used to complement …

Vimang is the brand name of formulations containing an extract of Mangifera indica L.,
ethnopharmacologically used in Cuba for the treatment of some immunopathological disorders, …

Background As a first step towards a vaccine protecting COVID-19 convalescents from
reinfection, we evaluated FINLAY-FR-1A vaccine in a clinical trial. Methods Thirty COVID-19 …

Background SOBERANA 02 is a COVID-19 vaccine based on SARS-CoV-2 recombinant
RBD conjugated to tetanus toxoid (TT). SOBERANA Plus antigen is dimeric-RBD. Here we …

Background SOBERANA-02 is a COVID-19 conjugate vaccine (recombinant RBD conjugated
to tetanus toxoid). Phases 1/2 clinical trials demonstrated high immunogenicity, promoting …

Objectives To evaluate a heterologous vaccination scheme in children 3-18 years old (y/o)
combining two SARS-CoV-2r- receptor binding domain (RBD)protein vaccines. Methods A …

Objectives The aim was to study the effects of Mangifera indica extract and its major component
mangiferin on lung inflammation response and Th2 cytokine production using a murine …

Background A phase 1, clinical trial to evaluate FINLAY-FR-1A vaccine in COVID-19
convalescent individuals was completed. Here, we report results of the phase 2, clinical trial. …

Background SOBERANA 02 has been evaluated in phase I and IIa studies comparing
homologous versus heterologous schedule (this one, including SOBERANA Plus). Here, we …

Controlling the global COVID-19 pandemic depends, among other measures, on developing
preventive vaccines at an unprecedented pace. Vaccines approved for use and those in …